Myokine mediated muscle-kidney crosstalk suppresses metabolic reprogramming and fibrosis in damaged kidneys
暂无分享,去创建一个
W. Mitch | B. Graham | Xin-Hua Feng | Zhaoyong Hu | Yanlin Wang | Feng Li | Hui Peng | T. Lou | Vivekananda Shetty | Qianqian Wang | Jun Qin | Sungyun Jung
[1] W. Aoi. Characteristics of Skeletal Muscle as a Secretory Organ , 2017 .
[2] Xiao-ming Meng,et al. TGF-β: the master regulator of fibrosis , 2016, Nature Reviews Nephrology.
[3] B. Spiegelman,et al. PTH/PTHrP Receptor Mediates Cachexia in Models of Kidney Failure and Cancer. , 2016, Cell metabolism.
[4] M. Bhasin,et al. PGC1α-dependent NAD biosynthesis links oxidative metabolism to renal protection , 2016, Nature.
[5] W. Mitch,et al. CKD Stimulates Muscle Protein Loss Via Rho-associated Protein Kinase 1 Activation. , 2016, Journal of the American Society of Nephrology : JASN.
[6] Youhua Liu,et al. Renal fibrosis in 2015: Understanding the mechanisms of kidney fibrosis , 2016, Nature Reviews Nephrology.
[7] C. Handschin,et al. Skeletal muscle as an endocrine organ: PGC-1α, myokines and exercise. , 2015, Bone.
[8] W. Mitch,et al. JAK3/STAT6 Stimulates Bone Marrow-Derived Fibroblast Activation in Renal Fibrosis. , 2015, Journal of the American Society of Nephrology : JASN.
[9] L. Truong,et al. Loss of PTEN promotes podocyte cytoskeletal rearrangement, aggravating diabetic nephropathy , 2015, The Journal of pathology.
[10] X. Sui,et al. Exercise capacity and risk of chronic kidney disease in US veterans: a cohort study. , 2015, Mayo Clinic proceedings.
[11] S. Allison. Fibrosis: Dysfunctional fatty acid oxidation in renal fibrosis , 2015, Nature Reviews Nephrology.
[12] Kumar Sharma,et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development , 2014, Nature Medicine.
[13] M. Okano,et al. Cohort Study , 2020, Definitions.
[14] P. D. De Jager,et al. Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes. , 2014, Journal of the American Society of Nephrology : JASN.
[15] Ina Schuppe-Koistinen,et al. Skeletal Muscle PGC-1α1 Modulates Kynurenine Metabolism and Mediates Resilience to Stress-Induced Depression , 2014, Cell.
[16] R. Zager,et al. Renal cortical pyruvate depletion during AKI. , 2014, Journal of the American Society of Nephrology : JASN.
[17] Yuan Zhang,et al. Irisin Stimulates Browning of White Adipocytes Through Mitogen-Activated Protein Kinase p38 MAP Kinase and ERK MAP Kinase Signaling , 2014, Diabetes.
[18] M. Febbraio,et al. Muscles, exercise and obesity: skeletal muscle as a secretory organ , 2012, Nature Reviews Endocrinology.
[19] B. Spiegelman,et al. A PGC1α-dependent myokine that drives browning of white fat and thermogenesis , 2012, Nature.
[20] Shingo,et al. A PGC1-\(\alpha\)-dependent Myokine that Drives Brown-fat-like Development of White Fat and Thermogenesis , 2012 .
[21] R. Robey. Hexokinase: a novel sugar kinase coupled to renal epithelial cell survival. , 2011, Kidney international.
[22] Steven P Jones,et al. Bioenergetic function in cardiovascular cells: the importance of the reserve capacity and its biological regulation. , 2011, Chemico-biological interactions.
[23] Wei Li,et al. TβRI/Alk5-independent TβRII signaling to ERK1/2 in human skin cells according to distinct levels of TβRII expression , 2011, Journal of Cell Science.
[24] R. Star,et al. Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. , 2010, Kidney international.
[25] T. Clemens,et al. TGF-β type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling , 2010, Nature Cell Biology.
[26] Qianqian Wang,et al. Single-molecule imaging reveals transforming growth factor-β-induced type II receptor dimerization , 2009, Proceedings of the National Academy of Sciences.
[27] R. Foley,et al. Prevalence of CKD in the United States: a sensitivity analysis using the National Health and Nutrition Examination Survey (NHANES) 1999-2004. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[28] Christoph Handschin,et al. The role of exercise and PGC1α in inflammation and chronic disease , 2008, Nature.
[29] Christoph Handschin,et al. The Role of Exercise and Pgc1alpha in Inflammation and Chronic Disease , 2022 .
[30] D. Nicholls,et al. Spare Respiratory Capacity Rather Than Oxidative Stress Regulates Glutamate Excitotoxicity after Partial Respiratory Inhibition of Mitochondrial Complex I with Rotenone , 2007, The Journal of Neuroscience.
[31] Kebin Hu,et al. hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists. , 2006, Journal of the American Society of Nephrology : JASN.
[32] Kebin Hu,et al. Hepatocyte Growth Factor Is a Downstream Effector that Mediates the Antifibrotic Action of Peroxisome Proliferator–Activated Receptor-γ Agonists , 2005 .
[33] Charles E McCulloch,et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.
[34] Ying E. Zhang,et al. Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.
[35] Li-jun Ma,et al. Model of robust induction of glomerulosclerosis in mice: importance of genetic background. , 2003, Kidney international.
[36] J. Massagué,et al. Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.
[37] J. Massagué,et al. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. , 2003, Cell.
[38] R. Derynck,et al. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. , 2003, Nature.
[39] L. Nolte,et al. Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC‐1 , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[40] Jiandie D. Lin,et al. Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres , 2002, Nature.
[41] Jiandie D. Lin,et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. , 2002, Nature.
[42] Hong-Jian Zhu,et al. A Pivotal Role for the Transmembrane Domain in Transforming Growth Factor-β Receptor Activation* , 1999, The Journal of Biological Chemistry.
[43] K. Nath. The tubulointerstitium in progressive renal disease. , 1998, Kidney international.
[44] A. S. Appel,et al. Acute Renal Failure , 1960, Advances in Experimental Medicine and Biology.